Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypersplenism.

M Peck-Radosavljevic1

  • 1Dept of Gastroenterology and Hepatology, University of Vienna Medical School, Vienna, Austria. markus.peck@akh-wien.ac.at

European Journal of Gastroenterology & Hepatology
|May 8, 2001
PubMed
Summary
This summary is machine-generated.

Cytopenias in liver disease are common and previously attributed to hypersplenism. Advances in hematopoiesis reveal new insights and therapeutic opportunities using hematopoietic growth factors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of patatin-like phospholipase domain containing 3 rs738409 G/G genotype on hepatic decompensation and mortality in patients with portal hypertension.

Alimentary pharmacology & therapeutics·2018
Same author

A multicentre, open-label, phase-I/randomised phase-II study to evaluate safety, pharmacokinetics, and efficacy of nintedanib vs. sorafenib in European patients with advanced hepatocellular carcinoma.

British journal of cancer·2018
Same author

Hepatitis C: The beginning of the end-key elements for successful European and national strategies to eliminate HCV in Europe.

Journal of viral hepatitis·2018
Same author

Carvedilol for reducing portal pressure in primary prophylaxis of variceal bleeding: a dose-response study.

Alimentary pharmacology & therapeutics·2018
Same author

Betablockers do not increase efficacy of band ligation in primary prophylaxis but they improve survival in secondary prophylaxis of variceal bleeding.

Alimentary pharmacology & therapeutics·2018
Same author

Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity.

Alimentary pharmacology & therapeutics·2018
Same journal

Comment on 'Associations between 12 insulin resistance surrogates with metabolic dysfunction-associated steatotic liver disease risk and all-cause mortality: data from the National Health and Nutrition Examination Survey III (1988-1994)'.

European journal of gastroenterology & hepatology·2026
Same journal

Alarm symptoms at diagnosis of coeliac disease and long-term outcomes.

European journal of gastroenterology & hepatology·2026
Same journal

Artificial intelligence-integrated nanotherapeutics for rare Peutz-Jeghers syndrome hamartoma-induced obstructions: latest clearance strategies.

European journal of gastroenterology & hepatology·2026
Same journal

'Presence of alarm symptoms at coeliac disease diagnosis is not associated with poorer long-term treatment outcomes' [Letter].

European journal of gastroenterology & hepatology·2026
Same journal

Atrial fibrillation in patients with alcohol-associated hepatitis leads to increased mortality.

European journal of gastroenterology & hepatology·2026
Same journal

Association between albumin-bilirubin score, model for end-stage liver disease score, platelet-albumin-bilirubin score, and acute-on-chronic liver failure complications: a cross-sectional study in a Chinese population.

European journal of gastroenterology & hepatology·2026
See all related articles

Area of Science:

  • Hematology
  • Hepatology
  • Immunology

Background:

  • Cytopenias (low blood cell counts) are frequently observed in patients with liver disease.
  • Historically, these cytopenias were primarily attributed to hypersplenism, involving blood cell pooling and destruction in an enlarged spleen.

Purpose of the Study:

  • To explore new insights into the pathophysiology of blood cell abnormalities in liver disease.
  • To investigate the potential of recombinant hematopoietic growth factors for patient support.

Main Methods:

  • Review of recent advances in understanding blood formation physiology.
  • Examination of the role of hematopoietic growth factors.

Main Results:

  • New understanding of blood cell derangements in liver disease pathophysiology.

Related Experiment Videos

  • Identification of recombinant hematopoietic growth factors as a therapeutic avenue.

    • Conclusions:

    • Recombinant hematopoietic growth factors offer novel support strategies for the hematopoietic system.
    • These factors are crucial for managing cytopenias in liver disease patients undergoing antiviral therapies or surgery.